Page 51 - Elements CHI New Revised 20200808

参考文献

9)Block, Gladys, et al. “Vitamin C treatment reduces elevated C-reactive protein.” Free Radical Biology and Medicine 46.1 (2009): 70-77.
10)Harrison, Stephen A., et al. “Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.” The American journal
of gastroenterology 98.11 (2003): 2485-2490.
11)Jarosz, M., et al. “Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice.” European
journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP) 7.6 (1998): 449-454.
12)Bucca, Caterina, et al. “Effect of vitamin C on histamine bronchial responsiveness of patients with allergic rhinitis.” Annals of allergy 65.4 (1990): 311-314.
13.Ruskin, Simon L. “Sodium ascorbate in the treatment of allergic disturbances.” The American journal of digestive diseases 14.9 (1947): 302)
14)Valero, María Pastor, et al. “Vitamin C is associated with reduced risk of cataract in a Mediterranean population.” The Journal of nutrition 132)6 (2002):
1299-1306.
15)Pauling, Linus. “Are recommended daily allowances for vitamin C adequate?.” Proceedings of the National Academy of Sciences 71.11 (1974): 4442-
4446.
16) Packer, Lester. Vitamin C in health and disease. Vol. 4. CRC Press, 1997.
烟酰胺
1)Crinò, Α., et al. “A Two Year Observational Study of Nicotinamide and Intensive Insulin Therapy in Patients with Recent Onset Type I Diabetes Mellitus.”
Journal of Pediatric Endocrinology and Metabolism 18.8 (2005): 749-754.
2)Cheng, Steven C., et al. “A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients.”
Clinical Journal of the American Society of Nephrology 3.4 (2008): 1131-1138.
3)Ginsberg, Charles, and Joachim H. Ix. “Nicotinamide and phosphate homeostasis in chronic kidney disease.” Current opinion in nephrology and
hypertension 25.4 (2016): 285.
4)Yiasemides, Eleni, et al. “Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans.” Carcinogenesis 30.1 (2009):
101-105.
5)Niren, Neil M. “Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review.” Cutis 77.1 Suppl (2006): 11-16.
6)Walocko, Frances M., et al. “The role of nicotinamide in acne treatment.” Dermatologic therapy 30.5 (2017): e12481.
7)Chen, Andrew C., et al. “A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention.” New England Journal of Medicine 373.17 (2015):
1618-1626.
8)Jonas, W. B., C. P. Rapoza, and W. F. Blair. “The effect of niacinamide on osteoarthritis: a pilot study.” Inflammation Research 45.7 (1996): 330-334.
9)Hakozaki, T., et al. “The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.” British Journal of
Dermatology 147.1 (2002): 20-31.
10)Navarrete-Solís, Josefina, et al. “A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma.”
Dermatology research and practice 2011 (2011).
11)Zackheim, Herschel S. “Topical 6-aminonicotinamide plus oral niacinamide therapy for psoriasis.” Archives of dermatology 114.11 (1978): 1632-1638.
12) Knip, M1, et al. “Safety of high-dose nicotinamide: a review.” Diabetologia 43.11 (2000): 1337-1345.
神奇的关节营养素
1)Stancikova, M., et al. “The effects of hyaluronan on bone resorption and bone mineral density in a rat model of estrogen deficiency-induced osteopenia.”
International journal of tissue reactions 26.1-2 (2004): 9-16.
2)Palmieri, B., et al. “Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo controlled study
for the treatment of symptoms in patients with non-erosive gastroesophageal reflux.” Eur Rev Med Pharmacol Sci 17.24 (2013): 3272-8.
3)Bowman, Steven, et al. “Recent advances in hyaluronic acid based therapy for osteoarthritis.” Clinical and translational medicine 7.1 (2018): 6.
4)Jensen, Gitte S., et al. “Oral intake of a liquid high-molecular-weight hyaluronan associated with relief of chronic pain and reduced use of pain medication:
Results of a randomized, placebo-controlled double-blind pilot study.” Journal of medicinal food 18.1 (2015): 95-101.
5)Oe, Mariko, et al. “Oral hyaluronan relieves knee pain: a review.” Nutrition journal 15.1 (2015): 11.
6)Kawada, Chinatsu, et al. “Ingested hyaluronan moisturizes dry skin.” Nutrition journal 13.1 (2014): 70.
7)Nipin, S. P., et al. “The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth
and metastasis in ER-positive breast cancer xenografts.” BMC cancer 15.1 (2015): 474.
8)Kang, Dong Young, et al. “Methylsulfonylmethane inhibits HER2 expression through STAT5b in breast cancer cells.” International journal of oncology
48.2 (2016): 836-842)
8)Caron, Joan McIntyre, et al. “Methyl sulfone induces loss of metastatic properties and reemergence of normal phenotypes in a metastatic cloudman S-91
(M3) murine melanoma cell line.” PLoS One 5.8 (2010).
8)Joung, Youn Hee, et al. “Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the
Jak2/STAT3 pathway.” International journal of oncology 44.3 (2014): 883-895.
8)Karabay, Arzu Zeynep, et al. “Methylsulfonylmethane induces P53 independent apoptosis in HCT-116 colon cancer cells.” International journal of
molecular sciences 17.7 (2016): 1123.
8)Kim, Joo-Hyun, et al. “Methylsulfonylmethane suppresses hepatic tumor development through activation of apoptosis.” World journal of hepatology
6.2 (2014): 98.
8)Jafari, Naser, et al. “Cytotoxicity of methylsulfonylmethane on gastrointestinal (AGS, HepG2, and KEYSE-30) cancer cell lines.” Journal of gastrointestinal
cancer 43.3 (2012): 420-425.
9)Kim, Seol-hee, et al. “MSM ameliorates HIV-1 Tat induced neuronal oxidative stress via rebalance of the glutathione cycle.” American journal of
translational research 7.2 (2015): 328.
10)Barmaki, S., et al. “Effect of methylsulfonylmethane supplementation on exercise-Induced muscle damage and total antioxidant capacity.” The Journal
of sports medicine and physical fitness 52)2 (2012): 170-174.
11)Gerhardt, H., et al. “Therapie des aktiven Morbus Crohn mit dem Boswellia-serrata-Extrakt H 15.” Zeitschrift für gastroenterologie 39.01 (2001): 11-17.
12)Chopra, A. R. V. I. N. D., et al. “Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis.” The
Journal of rheumatology 27.6 (2000): 1365-1372)
蕈类β葡聚糖
1)Chan, Godfrey Chi-Fung, Wing Keung Chan, and Daniel Man-Yuen Sze. “The effects of β-glucan on human immune and cancer cells.” Journal of
hematology & oncology 2)1 (2009): 25.
2)Wong, Kah-Hui, et al. “Neuroregenerative potential of lion’s mane mushroom, Hericium erinaceus (Bull.: Fr.) Pers.(higher Basidiomycetes), in the
treatment of peripheral nerve injury.” International journal of medicinal mushrooms 14.5 (2012).
3)Liu, Jianqing, et al. “Anti-fatigue activities of polysaccharides extracted from Hericium erinaceus.” Experimental and therapeutic medicine 9.2 (2015):
483-487.
4)Li, Guang, et al. “Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers.” Journal of ethnopharmacology 153.2
(2014): 521-530.
4)Lai, Wei Hong, Zamri Zainal, and Fauzi Daud. “Preliminary study on the potential of polysaccharide from indigenous Tiger’s Milk mushroom (Lignosus
rhinocerus) as anti-lung cancer agent.” AIP Conference Proceedings. Vol. 1614. No. 1. American Institute of Physics, 2014.
5)Lee, M. L., et al. “The antiproliferative activity of sclerotia of Lignosus rhinocerus (Tiger Milk Mushroom).” Evidence-based complementary and alternative
medicine 2012 (2012).
6)Yap, Hui-Yeng Y., et al. “Inhibition of protein glycation by tiger milk mushroom [Lignosus rhinocerus (Cooke) Ryvarden] and search for potential anti-
diabetic activity-related metabolic pathways by genomic and transcriptomic data mining.” Frontiers in pharmacology 9 (2018): 103.
7)Müller, Claudia I., et al. “Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells.” Leukemia research 30.7 (2006):
841-848.
51